306 related articles for article (PubMed ID: 24371056)
1. Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection.
Wang Z; Zhu K; Bai W; Jia B; Hu H; Zhou D; Zhang X; Zhang X; Xie Y; Bourgine MM; Michel ML; Lan K; Deng Q
J Virol; 2014 Mar; 88(5):3004-15. PubMed ID: 24371056
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus as a gene delivery vector activating foreign antigenic T cell response that abrogates viral expression in mouse models.
Deng Q; Mancini-Bourgine M; Zhang X; Cumont MC; Zhu R; Lone YC; Michel ML
Hepatology; 2009 Nov; 50(5):1380-91. PubMed ID: 19821533
[TBL] [Abstract][Full Text] [Related]
3. Characterization of IL-21-expressing recombinant hepatitis B virus (HBV) as a therapeutic agent targeting persisting HBV infection.
Shen Z; Wu J; Gao Z; Wang J; Zhu H; Mao R; Wang X; Zhang J; Xie Y; Liu J
Theranostics; 2020; 10(12):5600-5612. PubMed ID: 32373234
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances the hepatitis B virus-specific cytotoxic T-lymphocyte immune response and inhibits hepatitis B virus replication in transgenic mice.
Zhuo M; Song L; Tang Y; Dai S; Chen X; Yu Y; Zang G; Tang Z
Mol Med Rep; 2015 Sep; 12(3):3591-3598. PubMed ID: 26004262
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice.
Michler T; Kosinska AD; Festag J; Bunse T; Su J; Ringelhan M; Imhof H; Grimm D; Steiger K; Mogler C; Heikenwalder M; Michel ML; Guzman CA; Milstein S; Sepp-Lorenzino L; Knolle P; Protzer U
Gastroenterology; 2020 May; 158(6):1762-1775.e9. PubMed ID: 32001321
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.
Ren S; Nassal M
J Virol; 2001 Feb; 75(3):1104-16. PubMed ID: 11152483
[TBL] [Abstract][Full Text] [Related]
7. Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypes.
Godon O; Evlachev A; Bourgine M; Meritet JF; Martin P; Inchauspe G; Michel ML
Vaccine; 2015 Aug; 33(36):4548-53. PubMed ID: 26209840
[TBL] [Abstract][Full Text] [Related]
8. A Highly Attenuated Vesicular Stomatitis Virus-Based Vaccine Platform Controls Hepatitis B Virus Replication in Mouse Models of Hepatitis B.
Moshkani S; Chiale C; Lang SM; Rose JK; Robek MD
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541859
[TBL] [Abstract][Full Text] [Related]
9. High expression of hepatitis B virus based vector with reporter gene in hepatitis B virus infection system.
Li SH; Huang WG; Huang B; Chen XG
World J Gastroenterol; 2007 May; 13(17):2490-5. PubMed ID: 17552034
[TBL] [Abstract][Full Text] [Related]
10. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus vector carries a foreign gene into liver cells in vitro.
Yoo J; Rho J; Lee D; Shin S; Jung G
Virus Genes; 2002 Jun; 24(3):215-24. PubMed ID: 12086141
[TBL] [Abstract][Full Text] [Related]
12. Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver.
Dusséaux M; Masse-Ranson G; Darche S; Ahodantin J; Li Y; Fiquet O; Beaumont E; Moreau P; Rivière L; Neuveut C; Soussan P; Roingeard P; Kremsdorf D; Di Santo JP; Strick-Marchand H
Gastroenterology; 2017 Dec; 153(6):1647-1661.e9. PubMed ID: 28851562
[TBL] [Abstract][Full Text] [Related]
13. Approach to establishing a liver targeting gene therapeutic vector using naturally occurring defective hepatitis B viruses devoid of immunogenic T cell epitope.
Wang L; Kaneko S; Honda M; Kobayashi K
Virus Res; 2002 May; 85(2):187-97. PubMed ID: 12034485
[TBL] [Abstract][Full Text] [Related]
14. Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen.
Zhang TY; Yuan Q; Zhao JH; Zhang YL; Yuan LZ; Lan Y; Lo YC; Sun CP; Wu CR; Zhang JF; Zhang Y; Cao JL; Guo XR; Liu X; Mo XB; Luo WX; Cheng T; Chen YX; Tao MH; Shih JW; Zhao QJ; Zhang J; Chen PJ; Yuan YA; Xia NS
Gut; 2016 Apr; 65(4):658-71. PubMed ID: 26423112
[TBL] [Abstract][Full Text] [Related]
15. T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice.
Krebs K; Böttinger N; Huang LR; Chmielewski M; Arzberger S; Gasteiger G; Jäger C; Schmitt E; Bohne F; Aichler M; Uckert W; Abken H; Heikenwalder M; Knolle P; Protzer U
Gastroenterology; 2013 Aug; 145(2):456-65. PubMed ID: 23639914
[TBL] [Abstract][Full Text] [Related]
16. TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice.
Martin P; Dubois C; Jacquier E; Dion S; Mancini-Bourgine M; Godon O; Kratzer R; Lelu-Santolaria K; Evlachev A; Meritet JF; Schlesinger Y; Villeval D; Strub JM; Van Dorsselaer A; Marchand JB; Geist M; Brandely R; Findeli A; Boukhebza H; Menguy T; Silvestre N; Michel ML; Inchauspé G
Gut; 2015 Dec; 64(12):1961-71. PubMed ID: 25429051
[TBL] [Abstract][Full Text] [Related]
17. Immune-Mobilizing Monoclonal T Cell Receptors Mediate Specific and Rapid Elimination of Hepatitis B-Infected Cells.
Fergusson JR; Wallace Z; Connolly MM; Woon AP; Suckling RJ; Hine DW; Barber C; Bunjobpol W; Choi BS; Crespillo S; Dembek M; Dieckmann N; Donoso J; Godinho LF; Grant T; Howe D; McCully ML; Perot C; Sarkar A; Seifert FU; Singh PK; Stegmann KA; Turner B; Verma A; Walker A; Leonard S; Maini MK; Wiederhold K; Dorrell L; Simmons R; Knox A
Hepatology; 2020 Nov; 72(5):1528-1540. PubMed ID: 32770836
[TBL] [Abstract][Full Text] [Related]
18. Novel recombinant hepatitis B virus vectors efficiently deliver protein and RNA encoding genes into primary hepatocytes.
Hong R; Bai W; Zhai J; Liu W; Li X; Zhang J; Cui X; Zhao X; Ye X; Deng Q; Tiollais P; Wen Y; Liu J; Xie Y
J Virol; 2013 Jun; 87(12):6615-24. PubMed ID: 23552416
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Bioluminescence Imaging of HBV Replicating Hepatocytes Allows for the Monitoring of Anti-Viral Immunity.
Manske K; Schneider A; Ko C; Knolle PA; Steiger K; Protzer U; Wohlleber D
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835079
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
